Paper32447876
The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid.
Lee JY and 24 others. Ultrasonography, 2020. Cited by 85 papers, by iCite.
Cite this record
ConductScience Library. The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid. Papers, record 32447876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32447876
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AFSUMB | PubMed |
Source PubMed
References208
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24147489 | Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound. | AJR Am J Roentgenol | 2013 | https://conductscience.org/library/papers/24147489 | PubMed |
| 2 | 11879947 | Nonlinear acoustics in diagnostic ultrasound. | Ultrasound Med Biol | 2002 | https://conductscience.org/library/papers/11879947 | PubMed |
| 3 | 18561648 | Computer-aided diagnosis for the classification of focal liver lesions by use of contrast-enhanced ultrasonography. | Med Phys | 2008 | https://conductscience.org/library/papers/18561648 | PubMed |
| 4 | 11131461 | Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. | J Hepatol | 2000 | https://conductscience.org/library/papers/11131461 | PubMed |
| 5 | 26989659 | Breakthrough Imaging in Hepatocellular Carcinoma. | Liver Cancer | 2016 | https://conductscience.org/library/papers/26989659 | PubMed |
| 6 | 27067685 | [Evaluation of Sorafenib for Hepatocellular Carcinoma with Low α-Fetoprotein by Arrival Time Parametric Imaging Using Contrast-Enhanced Ultrasonography with Sonazoid]. | Gan To Kagaku Ryoho | 2016 | https://conductscience.org/library/papers/27067685 | PubMed |
| 7 | 19394876 | Improved detection of hepatic metastases with contrast-enhanced low mechanical-index pulse inversion ultrasonography during the liver-specific phase of sonazoid: observer performance study with JAFROC analysis. | Acad Radiol | 2009 | https://conductscience.org/library/papers/19394876 | PubMed |
| 8 | 21160724 | Contrast-enhanced harmonic ultrasound imaging in ablation therapy for primary hepatocellular carcinoma. | World J Radiol | 2009 | https://conductscience.org/library/papers/21160724 | PubMed |
| 9 | 23155317 | Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study. | World J Gastroenterol | 2012 | https://conductscience.org/library/papers/23155317 | PubMed |
| 10 | 9609893 | Abdominal percutaneous interventional procedures: comparison of CT and US guidance. | Radiology | 1998 | https://conductscience.org/library/papers/9609893 | PubMed |
| 11 | 17877482 | New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma. | Hepatol Res | 2007 | https://conductscience.org/library/papers/17877482 | PubMed |
| 12 | 2463674 | Transport polarity of hepatocytes. | Semin Liver Dis | 1988 | https://conductscience.org/library/papers/2463674 | PubMed |
| 13 | 20616583 | Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma. | Oncology | 2010 | https://conductscience.org/library/papers/20616583 | PubMed |
| 14 | 23137926 | Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. | Ultrasound Med Biol | 2013 | https://conductscience.org/library/papers/23137926 | PubMed |
| 15 | 24002440 | Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasound. | Abdom Imaging | 2014 | https://conductscience.org/library/papers/24002440 | PubMed |
| 16 | 20232404 | Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography. | J Clin Ultrasound | 2010 | https://conductscience.org/library/papers/20232404 | PubMed |
| 17 | 17351779 | Microbubble ultrasound contrast agents: an update. | Eur Radiol | 2007 | https://conductscience.org/library/papers/17351779 | PubMed |
| 18 | 31031037 | Flash Imaging Used in the Post-vascular Phase of Contrast-Enhanced Ultrasonography is Useful for Assessing the Progression in Patients with Hepatitis C Virus-Related Liver Disease. | Ultrasound Med Biol | 2019 | https://conductscience.org/library/papers/31031037 | PubMed |
| 19 | 30478647 | Differential diagnosis of gallbladder polypoid lesions using contrast-enhanced ultrasound. | Abdom Radiol (NY) | 2019 | https://conductscience.org/library/papers/30478647 | PubMed |
| 20 | 21080306 | Quantitative contrast-enhanced harmonic endoscopic ultrasonography for the discrimination of solid pancreatic masses. | Ultraschall Med | 2010 | https://conductscience.org/library/papers/21080306 | PubMed |
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42670434 | Liver Imaging Reporting and Data System (LI-RADS): A Comprehensive Review. | Cureus | 2026 | https://conductscience.org/library/papers/42670434 | PubMed |
| 42220053 | Predictors of tumor conspicuity on Kupffer-phase Sonazoid-enhanced ultrasonography in liver tumors: implications for fusion-guided ablation. | Ultrasonography | 2026 | https://conductscience.org/library/papers/42220053 | PubMed |
| 41802327 | Low-mechanical-index B-mode phase-inversion harmonic imaging significantly improves hepatic lesion conspicuity during Sonazoid Kupffer phase: a prospective comparative study. | Ultrasonography | 2026 | https://conductscience.org/library/papers/41802327 | PubMed |
| 41802321 | Ultrasound-guided ablation of hepatocellular carcinoma: a review of its past, present, and future. | Ultrasonography | 2026 | https://conductscience.org/library/papers/41802321 | PubMed |
| 40928383 | Expert consensus regarding the clinical application of liver contrast-enhanced US with Sonazoid (Sonazoid CEUS). | Int J Surg | 2026 | https://conductscience.org/library/papers/40928383 | PubMed |
| 40310346 | Washout on Contrast-Enhanced Ultrasound of Benign Focal Liver Lesions-A Review on Its Frequency and Possible Causes. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40310346 | PubMed |
| 40265389 | Diagnostic Accuracy of Sonazoid-Enhanced Ultrasonography for Detection of Liver Metastasis. | Med Sci (Basel) | 2025 | https://conductscience.org/library/papers/40265389 | PubMed |
| 40200415 | Characterization of non-alcoholic fatty liver disease-related hepatocellular carcinoma on contrast-enhanced ultrasound with Sonazoid. | Ultrasonography | 2025 | https://conductscience.org/library/papers/40200415 | PubMed |
| 40116886 | LI-RADS for diagnosing hepatocellular carcinoma by contrast-enhanced US with SonoVue and Sonazoid-a single center prospective study. | Abdom Radiol (NY) | 2025 | https://conductscience.org/library/papers/40116886 | PubMed |
| 39609743 | Contrast-enhanced ultrasonography guidance avoids US-CT/MR fusion error for percutaneous radiofrequency ablation of hepatocellular carcinoma. | BMC Med Imaging | 2024 | https://conductscience.org/library/papers/39609743 | PubMed |
| 39525688 | Liver microvascular flow evaluation by texture analysis and quantitative contrast-enhanced ultrasound in pediatric chronic liver disease. | IEEE South Asian Ultrason Symp | 2024 | https://conductscience.org/library/papers/39525688 | PubMed |
| 39480596 | Diagnostic performance of Sonazoid-enhanced CEUS in identifying definitive hepatocellular carcinoma in cirrhotic patients according to KLCA-NCC 2022 and APASL 2017 guidelines. | Insights Imaging | 2024 | https://conductscience.org/library/papers/39480596 | PubMed |
| 39402127 | A non-invasive predictive model based on multimodality ultrasonography images to differentiate malignant from benign focal liver lesions. | Sci Rep | 2024 | https://conductscience.org/library/papers/39402127 | PubMed |
| 39223081 | Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association. | Gut Liver | 2024 | https://conductscience.org/library/papers/39223081 | PubMed |
| 39210668 | Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association. | J Liver Cancer | 2024 | https://conductscience.org/library/papers/39210668 | PubMed |
| 39197823 | Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association. | Korean J Radiol | 2024 | https://conductscience.org/library/papers/39197823 | PubMed |
| 39174799 | Current status and future perspectives of contrast-enhanced ultrasound diagnosis of breast lesions. | J Med Ultrason (2001) | 2024 | https://conductscience.org/library/papers/39174799 | PubMed |
| 38805727 | Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024. | Radiology | 2024 | https://conductscience.org/library/papers/38805727 | PubMed |
| 38787832 | Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma. | PLoS One | 2024 | https://conductscience.org/library/papers/38787832 | PubMed |
| 38744698 | A combined model based on radiomics features of Sonazoid contrast-enhanced ultrasound in the Kupffer phase for the diagnosis of well-differentiated hepatocellular carcinoma and atypical focal liver lesions: a prospective, multicenter study. | Abdom Radiol (NY) | 2024 | https://conductscience.org/library/papers/38744698 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| GPT | 2875 | PubTator's text mining | https://conductscience.org/library/genes/2875 | NCBI Gene |
| HNF1A | 6927 | PubTator's text mining | https://conductscience.org/library/genes/6927 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32447876
GET https://conductscience.org/api/papers/v1/32447876/authors?page=2